Bisolvon^®

Unique and comforting solutions for chesty coughs

Coughing can be a distressful and uncomfortable experience. It is, however, an integral part of the body's self-cleaning mechanism and part of the body's self-protective response. A cough mainly has the function of clearing the airways, thereby protecting the lungs.

From a medical perspective, cough is the most common symptom of clinical importance and the most frequent reason to consult a doctor.  The clinical symptoms of cough and expectoration (coughing up mucus) have led to the development of drugs that affect respiratory mucus: the so-called mucoactive agents.

Basically, there are two kinds of cough during a common cold infection: chesty (productive) and dry (non-productive, persistent, and irritating). A chesty cough, also known as a productive cough, is normally the result of a viral upper respiratory tract infection, such as the common cold. The infection causes the mucous membrane of the airways to become inflamed and to produce thick, sticky mucus, so that it is no longer removed by the body’s normal cleaning action and clogs up the airways. Coughing helps push out this sticky phlegm. Inflammation and too much thick mucus narrow the airways, make breathing difficult, and can promote bacterial infection.

A non-productive cough is dry and tickling - a repeated irritation of the respiratory tract, usually without producing phlegm. Besides respiratory tract infections, this cough can for example also be caused by cigarette smoke, dust or allergies. Sometimes it remains for a couple of days or even weeks as a post symptom of a common cold.

Bromhexine, the active agent in Bisolvon^® is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion making it more easily to be expectorated. Bromhexine enhances also mucus transport by reducing mucus viscosity and by activating the ciliated epithelium. In clinical studies, Bisolvon^® showed secretolytic and secretomotoric effects in the bronchial tract area which facilitates expectoration and eases cough.

Bisolvon^® has been on the market since 1963. Bromhexine is contained in various formulations of Bisolvon^®. There are high and low strength syrups 8mg/5ml, 4 mg/ml, tablets and fast dissolving tablets (both with 8 mg bromhexine) and solution for oral use 10 mg/ 5 ml), adapted to the need of the patients. The posology varies with the age, but there are products for all age groups from infant on.

Beyond the cough indications, Bisolvon^® offers a variety of cough and cold products in different formats.

Bisolvon^® trusted to care for cough and colds.

Read the patient information leaflet carefully. If you have any questions, ask your doctor or pharmacist.

Local Websites